Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
US5807836A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Feb 23, 1995 |
| Grant date | Sep 15, 1998 |
| Priority date | — |
| Expiry date | Feb 23, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to a method of diagnosing tumorigenic mammalian cells or the propensity of a mammalian cell to become tumorigenetic. Additionally, the present invention relates to a cloned cDNA or genomic DNA for reducing the propensity of a cell to become tumorigenic or suppressing tumorigenic phenotype of a cell; a method of reducing the propensity of a cell to become tumorigenic or suppressing the tumorigenic phenotype of a cell; a method of treating a patient suffering from or predisposed to subsequent cancer development; and a method of diagnosing tumorigenic tissue of a human or tissue predisposed to become tumorigenic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.